首页 > 最新文献

Ophthalmic Plastic and Reconstructive Surgery最新文献

英文 中文
Pilomatrixoma of the Periorbital Region: A Retrospective Review. 眶周枕状瘤:回顾性综述
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-10 DOI: 10.1097/IOP.0000000000002731
Amitouj S Sidhu, Alexandra Allende, Andrew Gal, Krishna Tumuluri

Purpose: Pilomatrixoma is a benign cutaneous adnexal tumor that differentiates toward hair follicle cells. It infrequently occurs in the periorbital region. In the periorbital area, it is often located in the upper eyelid and eyebrow region. Periorbital pilomatrixoma is often misdiagnosed clinically and is less common than other benign skin tumors. In this retrospective review, we evaluate the demographic, clinical, and histopathological data of patients with periorbital pilomatrixoma, treated from 2010 to 2023.

Methods: A retrospective analysis of periorbital pilomatrixoma cases treated during a period of 13 years was performed. Deidentified data in relation to the age at surgical excision, gender, location, size, histopathological features, treatment, and recurrence were collected. All histological slides were reviewed by an attending histopathologist.

Results: A total of 77 cases of periorbital pilomatrixoma were diagnosed by histopathological examination and treated from 2010 to 2023. A slight female preponderance (56%) was noted, and the majority of cases (52%) were presented in the first 2 decades of life. The left periorbital region was involved in 45.5% of cases, and 54.5% in the right. The upper lid was the most affected site. Two cases of recurrence were reported. No malignant transformation was noted.

Conclusions: Pilomatrixoma is an uncommon benign periorbital tumor, commonly misdiagnosed clinically. Ophthalmologists and surgeons should suspect pilomatrixoma in the periorbital region, especially in children or young adults. Complete surgical excision is curative, and recurrence is rare.

目的:毛囊母细胞瘤是一种向毛囊细胞分化的良性皮肤附件肿瘤。它很少发生在眶周部位。在眶周,它通常位于上眼睑和眉毛区域。眶周皮母细胞瘤在临床上经常被误诊,而且比其他良性皮肤肿瘤更少见。在这篇回顾性文章中,我们评估了2010年至2023年接受治疗的眶周皮母细胞瘤患者的人口统计学、临床和组织病理学数据:我们对13年间接受治疗的眶周皮母细胞瘤病例进行了回顾性分析。收集了与手术切除年龄、性别、位置、大小、组织病理学特征、治疗和复发有关的去身份化数据。所有组织病理切片均由一名主治组织病理学家审阅:结果:2010年至2023年期间,共有77例眶周皮母细胞瘤患者通过组织病理学检查确诊并接受了治疗。其中女性略占多数(56%),大多数病例(52%)出现在生命的最初20年。45.5%的病例累及左侧眶周,54.5%的病例累及右侧眶周。上睑是发病率最高的部位。有两例复发病例。未发现恶性转化:结论:枕母细胞瘤是一种不常见的眶周良性肿瘤,临床上常被误诊。眼科医生和外科医生应怀疑眶周有皮下母细胞瘤,尤其是儿童或年轻人。完全手术切除是治愈性的,很少复发。
{"title":"Pilomatrixoma of the Periorbital Region: A Retrospective Review.","authors":"Amitouj S Sidhu, Alexandra Allende, Andrew Gal, Krishna Tumuluri","doi":"10.1097/IOP.0000000000002731","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002731","url":null,"abstract":"<p><strong>Purpose: </strong>Pilomatrixoma is a benign cutaneous adnexal tumor that differentiates toward hair follicle cells. It infrequently occurs in the periorbital region. In the periorbital area, it is often located in the upper eyelid and eyebrow region. Periorbital pilomatrixoma is often misdiagnosed clinically and is less common than other benign skin tumors. In this retrospective review, we evaluate the demographic, clinical, and histopathological data of patients with periorbital pilomatrixoma, treated from 2010 to 2023.</p><p><strong>Methods: </strong>A retrospective analysis of periorbital pilomatrixoma cases treated during a period of 13 years was performed. Deidentified data in relation to the age at surgical excision, gender, location, size, histopathological features, treatment, and recurrence were collected. All histological slides were reviewed by an attending histopathologist.</p><p><strong>Results: </strong>A total of 77 cases of periorbital pilomatrixoma were diagnosed by histopathological examination and treated from 2010 to 2023. A slight female preponderance (56%) was noted, and the majority of cases (52%) were presented in the first 2 decades of life. The left periorbital region was involved in 45.5% of cases, and 54.5% in the right. The upper lid was the most affected site. Two cases of recurrence were reported. No malignant transformation was noted.</p><p><strong>Conclusions: </strong>Pilomatrixoma is an uncommon benign periorbital tumor, commonly misdiagnosed clinically. Ophthalmologists and surgeons should suspect pilomatrixoma in the periorbital region, especially in children or young adults. Complete surgical excision is curative, and recurrence is rare.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141564006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply Re: "Outcome Comparison of Transconjunctival Müller's Muscle Recession With Levator Disinsertion (TMRLD) to Gold Weight Implantation in the Treatment of Paralytic Lagophthalmos". 回复"经结膜 Müller 肌肉回缩与提上睑肌植入术 (TMRLD) 与黄金重量植入术治疗麻痹性眼睑下垂的效果比较"。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-03 DOI: 10.1097/IOP.0000000000002742
H B Harold Lee
{"title":"Reply Re: \"Outcome Comparison of Transconjunctival Müller's Muscle Recession With Levator Disinsertion (TMRLD) to Gold Weight Implantation in the Treatment of Paralytic Lagophthalmos\".","authors":"H B Harold Lee","doi":"10.1097/IOP.0000000000002742","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002742","url":null,"abstract":"","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: "Ten-Year Follow Up of Orbital Volume Augmentation With Calcium Hydroxyapatite Filler in Postenucleation Socket Syndrome". 关于"用羟基磷灰石钙填充物增加眼眶容量治疗核磁共振后眼窝综合征的十年随访"。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-03 DOI: 10.1097/IOP.0000000000002655
S Elizabeth Dugan, Moshen B Kashkouli, Christopher J Compton, Jeremy D Clark
{"title":"Re: \"Ten-Year Follow Up of Orbital Volume Augmentation With Calcium Hydroxyapatite Filler in Postenucleation Socket Syndrome\".","authors":"S Elizabeth Dugan, Moshen B Kashkouli, Christopher J Compton, Jeremy D Clark","doi":"10.1097/IOP.0000000000002655","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002655","url":null,"abstract":"","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply Re: "Buffered Versus Nonbuffered Local Anesthetics and Local Pain Scores in Upper Eyelid Blepharoplasty: Randomized Controlled Trial". 回复"上眼睑眼袋整形术中缓冲局麻药与非缓冲局麻药和局部疼痛评分:随机对照试验"。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-03 DOI: 10.1097/IOP.0000000000002715
Dolika D Vasović, Miodrag Lj Karamarković
{"title":"Reply Re: \"Buffered Versus Nonbuffered Local Anesthetics and Local Pain Scores in Upper Eyelid Blepharoplasty: Randomized Controlled Trial\".","authors":"Dolika D Vasović, Miodrag Lj Karamarković","doi":"10.1097/IOP.0000000000002715","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002715","url":null,"abstract":"","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma. 泪腺腺癌与泪腺腺样囊性癌的临床病理特征和疗效比较
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-03 DOI: 10.1097/IOP.0000000000002606
Hila Goldberg, Xinyang Jiang, Janet Fan, Jiawei Zhao, Jing Ning, Michelle Williams, Steven Frank, Amy Moreno, Brandon Gunn, Renata Ferrarotto, Bita Esmaeli

Purpose: Lacrimal gland (LG) adenocarcinomas (ACs) are rare, with limited data. We compared clinicopathologic features and local recurrence, distant metastasis, and survival rates between LG AC and LG adenoid cystic carcinoma (ACC).

Methods: The records of LG AC patients treated from 2008 to 2022 and LG ACC patients treated from 1998 to 2022 at the same center were retrospectively reviewed.

Results: The study included 20 patients with AC; 10 de-novo AC, 10 ex-pleomorphic AC; and 51 ACC patients. The median age at diagnosis was 61 years for de-novo AC, 54 years for ex-pleomorphic AC, and 45 years for ACC. All groups had male predominance. The initial T category was T2 in 50% (5/10) of de-novo ACs; 60% (6/10) of ex-pleomorphic ACs; and 59% (30/51) of ACCs. Perineural invasion was present in 33% (5/15) of ACs and 90% (45/50) of ACCs ( p < 0.001). Of the 20 AC patients, 14 had eye-sparing surgery; 4 had orbital exenteration; and 2 had unresectable disease. All AC patients received postoperative radiotherapy and 15 (75%) received concurrent chemotherapy. Fourteen AC patients were tested for human growth factor receptor 2 expression, and 10 (71%) were human growth factor receptor 2 positive; 5 received human growth factor receptor 2-targeted therapy. AC and ACC had similar 5-year recurrence rates (20% and 33%, respectively, p = 0.31) and metastasis rates (20% and 34%, respectively, p = 0.30). de-novo AC, ex-pleomorphic AC, and ACC had similar 5-year disease-specific survival rates (80%, 79%, and 81%, respectively, p > 0.99).

Conclusions: LG AC and ACC have similar baseline clinicopathologic features, except that perineural invasion is more common in ACC, and similar recurrence, metastasis, and survival rates. Human growth factor receptor 2-targeted therapy may be appropriate in some patients with LG AC.

目的:泪腺腺癌(AC)非常罕见,数据有限。我们比较了LG AC和LG腺样囊性癌(ACC)的临床病理特征、局部复发率、远处转移率和生存率:方法:回顾性分析2008年至2022年在同一中心接受治疗的LG AC患者和1998年至2022年在同一中心接受治疗的LG ACC患者的病历:研究纳入了20名AC患者;10名去原发AC患者、10名前原发AC患者和51名ACC患者。诊断时的中位年龄为:去原发型 AC 61 岁,前pleomorphic AC 54 岁,ACC 45 岁。所有组别均以男性为主。50%(5/10)的去原发性前列腺癌、60%(6/10)的原前列腺癌和59%(30/51)的前列腺癌的初始T分类为T2。33%(5/15)的 AC 和 90%(45/50)的 ACC 存在神经周围侵犯(p < 0.001)。在20例ACC患者中,14例接受了保眼手术,4例进行了眼眶外扩张术,2例无法切除。所有 AC 患者都接受了术后放疗,15 名患者(75%)同时接受了化疗。14名AC患者接受了人类生长因子受体2表达检测,其中10人(71%)为人类生长因子受体2阳性;5人接受了人类生长因子受体2靶向治疗。AC和ACC的5年复发率(分别为20%和33%,P = 0.31)和转移率(分别为20%和34%,P = 0.30)相似。去原发AC、去原发AC和ACC的5年疾病特异性生存率相似(分别为80%、79%和81%,P > 0.99):LG AC和ACC具有相似的基线临床病理特征,只是ACC的神经周围侵犯更常见,而且复发率、转移率和生存率也相似。人类生长因子受体2靶向治疗可能适用于部分LG AC患者。
{"title":"Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma.","authors":"Hila Goldberg, Xinyang Jiang, Janet Fan, Jiawei Zhao, Jing Ning, Michelle Williams, Steven Frank, Amy Moreno, Brandon Gunn, Renata Ferrarotto, Bita Esmaeli","doi":"10.1097/IOP.0000000000002606","DOIUrl":"10.1097/IOP.0000000000002606","url":null,"abstract":"<p><strong>Purpose: </strong>Lacrimal gland (LG) adenocarcinomas (ACs) are rare, with limited data. We compared clinicopathologic features and local recurrence, distant metastasis, and survival rates between LG AC and LG adenoid cystic carcinoma (ACC).</p><p><strong>Methods: </strong>The records of LG AC patients treated from 2008 to 2022 and LG ACC patients treated from 1998 to 2022 at the same center were retrospectively reviewed.</p><p><strong>Results: </strong>The study included 20 patients with AC; 10 de-novo AC, 10 ex-pleomorphic AC; and 51 ACC patients. The median age at diagnosis was 61 years for de-novo AC, 54 years for ex-pleomorphic AC, and 45 years for ACC. All groups had male predominance. The initial T category was T2 in 50% (5/10) of de-novo ACs; 60% (6/10) of ex-pleomorphic ACs; and 59% (30/51) of ACCs. Perineural invasion was present in 33% (5/15) of ACs and 90% (45/50) of ACCs ( p < 0.001). Of the 20 AC patients, 14 had eye-sparing surgery; 4 had orbital exenteration; and 2 had unresectable disease. All AC patients received postoperative radiotherapy and 15 (75%) received concurrent chemotherapy. Fourteen AC patients were tested for human growth factor receptor 2 expression, and 10 (71%) were human growth factor receptor 2 positive; 5 received human growth factor receptor 2-targeted therapy. AC and ACC had similar 5-year recurrence rates (20% and 33%, respectively, p = 0.31) and metastasis rates (20% and 34%, respectively, p = 0.30). de-novo AC, ex-pleomorphic AC, and ACC had similar 5-year disease-specific survival rates (80%, 79%, and 81%, respectively, p > 0.99).</p><p><strong>Conclusions: </strong>LG AC and ACC have similar baseline clinicopathologic features, except that perineural invasion is more common in ACC, and similar recurrence, metastasis, and survival rates. Human growth factor receptor 2-targeted therapy may be appropriate in some patients with LG AC.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139692571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Incidence of Strabismus After Upper and Lower Blepharoplasty in the United States. 美国上下眼睑整形术后斜视的发生率。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-02-09 DOI: 10.1097/IOP.0000000000002617
Isdin Oke, Tobias Elze, Joan W Miller, Alice C Lorch, David G Hunter, Suzanne K Freitag, Linda R Dagi

Purpose: To compare the incidence of strabismus after upper and lower blepharoplasty in the United States.

Methods: Retrospective cohort study of adults (age ≥18 years) in the IRIS Registry (Intelligent Research in Sight) who underwent blepharoplasty between January 1, 2013 and December 31, 2020. The primary outcome was the Kaplan-Meier estimated cumulative incidence of strabismus diagnosis and surgery within 3 years of blepharoplasty. Multivariable Cox regression was used to determine the association of blepharoplasty type with strabismus diagnosis and surgery, adjusting for patient age, sex, and geographic region.

Results: Blepharoplasty was performed in 368,623 patients (median [interquartile range] age, 69 [63-75] years, and 69% female). Compared with those undergoing upper eyelid blepharoplasty, patients treated with lower eyelid blepharoplasty were slightly younger (median age, 66 vs. 69 years; p < 0.001) and more likely to be female (71% vs. 69%; p < 0.001). There was a greater 3-year incidence of strabismus diagnosis (2.0% vs. 1.5%; p < 0.001) and a greater 3-year incidence of strabismus surgery (0.15% vs. 0.06%; p = 0.003) for individuals undergoing lower vs. upper blepharoplasty. After adjusting for age, sex, and geographic region, lower blepharoplasty was associated with a higher 3-year risk of strabismus diagnosis (HR, 1.49; 95% CI, 1.23-1.81; p < 0.001) and surgery (HR, 2.53; 95% CI, 1.27-5.03; p = 0.008).

Conclusions: This registry-based analysis found that individuals undergoing lower eyelid blepharoplasty were at higher risk of strabismus compared with those undergoing upper eyelid blepharoplasty. Using large databases to understand the incidence of complications of frequently performed procedures may improve ophthalmologists' ability to provide data-driven counseling on surgical risks prior to intervention.

目的:比较美国上下眼睑成形术后斜视的发生率:回顾性队列研究:IRIS Registry(Intelligent Research in Sight,视力智能研究)中在 2013 年 1 月 1 日至 2020 年 12 月 31 日期间接受眼睑成形术的成年人(年龄≥18 岁)。主要结果是眼睑成形术后 3 年内斜视诊断和手术的 Kaplan-Meier 估计累积发生率。多变量 Cox 回归用于确定眼睑成形术类型与斜视诊断和手术的相关性,并对患者的年龄、性别和地理区域进行调整:共有 368,623 名患者接受了眼睑整形手术(中位数[四分位数间距]年龄为 69 [63-75] 岁,69% 为女性)。与接受上眼睑眼睑成形术的患者相比,接受下眼睑眼睑成形术的患者年龄略低(中位年龄为 66 岁对 69 岁;P < 0.001),女性比例更高(71% 对 69%;P < 0.001)。接受下眼睑成形术的患者与接受上眼睑成形术的患者相比,3年斜视诊断率更高(2.0% 对 1.5%;P < 0.001),3年斜视手术率更高(0.15% 对 0.06%;P = 0.003)。在对年龄、性别和地理区域进行调整后,下睑成形术与较高的3年斜视诊断风险(HR,1.49;95% CI,1.23-1.81;p < 0.001)和手术风险(HR,2.53;95% CI,1.27-5.03;p = 0.008)相关:这项基于登记的分析发现,与接受上眼睑眼睑成形术的患者相比,接受下眼睑眼睑成形术的患者患斜视的风险更高。利用大型数据库来了解经常进行的手术的并发症发生率,可以提高眼科医生的能力,在干预前提供以数据为导向的手术风险咨询。
{"title":"The Incidence of Strabismus After Upper and Lower Blepharoplasty in the United States.","authors":"Isdin Oke, Tobias Elze, Joan W Miller, Alice C Lorch, David G Hunter, Suzanne K Freitag, Linda R Dagi","doi":"10.1097/IOP.0000000000002617","DOIUrl":"10.1097/IOP.0000000000002617","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the incidence of strabismus after upper and lower blepharoplasty in the United States.</p><p><strong>Methods: </strong>Retrospective cohort study of adults (age ≥18 years) in the IRIS Registry (Intelligent Research in Sight) who underwent blepharoplasty between January 1, 2013 and December 31, 2020. The primary outcome was the Kaplan-Meier estimated cumulative incidence of strabismus diagnosis and surgery within 3 years of blepharoplasty. Multivariable Cox regression was used to determine the association of blepharoplasty type with strabismus diagnosis and surgery, adjusting for patient age, sex, and geographic region.</p><p><strong>Results: </strong>Blepharoplasty was performed in 368,623 patients (median [interquartile range] age, 69 [63-75] years, and 69% female). Compared with those undergoing upper eyelid blepharoplasty, patients treated with lower eyelid blepharoplasty were slightly younger (median age, 66 vs. 69 years; p < 0.001) and more likely to be female (71% vs. 69%; p < 0.001). There was a greater 3-year incidence of strabismus diagnosis (2.0% vs. 1.5%; p < 0.001) and a greater 3-year incidence of strabismus surgery (0.15% vs. 0.06%; p = 0.003) for individuals undergoing lower vs. upper blepharoplasty. After adjusting for age, sex, and geographic region, lower blepharoplasty was associated with a higher 3-year risk of strabismus diagnosis (HR, 1.49; 95% CI, 1.23-1.81; p < 0.001) and surgery (HR, 2.53; 95% CI, 1.27-5.03; p = 0.008).</p><p><strong>Conclusions: </strong>This registry-based analysis found that individuals undergoing lower eyelid blepharoplasty were at higher risk of strabismus compared with those undergoing upper eyelid blepharoplasty. Using large databases to understand the incidence of complications of frequently performed procedures may improve ophthalmologists' ability to provide data-driven counseling on surgical risks prior to intervention.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11226363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139723559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: "Neutrophil-to-Lymphocyte Ratios Distinguish Idiopathic Orbital Inflammation From Orbital Infectious Disease". 关于"中性粒细胞与淋巴细胞比率可区分特发性眼眶炎症和眼眶感染性疾病》。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-07-03 DOI: 10.1097/IOP.0000000000002727
Shreeya Hinge, Dayakar Yadalla, Rajagopalan Jayagayathri
{"title":"Re: \"Neutrophil-to-Lymphocyte Ratios Distinguish Idiopathic Orbital Inflammation From Orbital Infectious Disease\".","authors":"Shreeya Hinge, Dayakar Yadalla, Rajagopalan Jayagayathri","doi":"10.1097/IOP.0000000000002727","DOIUrl":"https://doi.org/10.1097/IOP.0000000000002727","url":null,"abstract":"","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soft Tissue Robotic Assisted Orbital Surgery Using da Vinci SP: A Cadaveric Experience. 使用达芬奇 SP 的软组织机器人辅助眼眶手术:尸体体验。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-01-17 DOI: 10.1097/IOP.0000000000002597
Jack Faulkner, Mohsan Malik, Claire Daniel, Jimmy Uddin, Asit Arora, Hubert Stein, Jean-Pierre Jeannon

Purpose: Robotic surgical techniques have transformed many surgical specialties however robotic techniques and applications have been much more limited in ophthalmology. This study aims to evaluate the feasibility of robotic assisted orbital surgery using a single-port novel robotic platform, the da Vinci SP.

Methods: A series of orbital procedures were performed in cadaveric specimens utilizing the da Vinci SP robotic system. The procedures performed included lacrimal gland dissection and biopsy, medial and lateral orbital wall dissections, enucleation, and lid-sparing orbital exenteration. Successful completion of each procedure was defined by the operating surgeon and was considered the primary outcome and marker of feasibility.

Results: Seven cadaveric procedures were performed in 3 cadaveric specimens. All 7 procedures were completed successfully without complication. Setup optimization occurred throughout the study and setup and operative times were acceptable. Three instrument arms and 1 endoscope were utilized throughout the study allowing 3 arm operating and dynamic retraction. Instrument size was found to limit surgical access and precision particular at the orbital apex.

Conclusions: This preclinical study demonstrates that the da Vinci SP can be utilized within the orbit and is feasible for several applications. Robotic surgical systems offer significant advantages over conventional techniques and should be embraced. However, current commercially available robotic platforms are not optimized for the orbit and have their limitations although they may be suitable for some clinical applications.

目的:机器人手术技术已经改变了许多外科专科,但机器人技术和应用在眼科领域却非常有限。本研究旨在评估使用单孔新型机器人平台达芬奇 SP 进行机器人辅助眼眶手术的可行性:方法:利用达芬奇 SP 机器人系统对尸体标本进行了一系列眼眶手术。所进行的手术包括泪腺解剖和活检、内侧和外侧眶壁解剖、去核和保睑眶外扩张术。每项手术的成功完成由手术医生确定,并被视为主要结果和可行性的标志:结果:在 3 具尸体标本上进行了 7 项尸体手术。所有 7 个手术均顺利完成,无并发症发生。在整个研究过程中进行了设置优化,设置和手术时间均可接受。整个研究过程中使用了三个器械臂和一个内窥镜,允许三臂操作和动态回缩。研究发现,器械的大小限制了手术的入路和精确度,尤其是在眶顶:这项临床前研究表明,达芬奇SP可以在眼眶内使用,并可用于多种应用。与传统技术相比,机器人手术系统具有显著优势,应予以推广。然而,目前市面上销售的机器人平台并没有针对眼眶进行优化,虽然可能适合某些临床应用,但也有其局限性。
{"title":"Soft Tissue Robotic Assisted Orbital Surgery Using da Vinci SP: A Cadaveric Experience.","authors":"Jack Faulkner, Mohsan Malik, Claire Daniel, Jimmy Uddin, Asit Arora, Hubert Stein, Jean-Pierre Jeannon","doi":"10.1097/IOP.0000000000002597","DOIUrl":"10.1097/IOP.0000000000002597","url":null,"abstract":"<p><strong>Purpose: </strong>Robotic surgical techniques have transformed many surgical specialties however robotic techniques and applications have been much more limited in ophthalmology. This study aims to evaluate the feasibility of robotic assisted orbital surgery using a single-port novel robotic platform, the da Vinci SP.</p><p><strong>Methods: </strong>A series of orbital procedures were performed in cadaveric specimens utilizing the da Vinci SP robotic system. The procedures performed included lacrimal gland dissection and biopsy, medial and lateral orbital wall dissections, enucleation, and lid-sparing orbital exenteration. Successful completion of each procedure was defined by the operating surgeon and was considered the primary outcome and marker of feasibility.</p><p><strong>Results: </strong>Seven cadaveric procedures were performed in 3 cadaveric specimens. All 7 procedures were completed successfully without complication. Setup optimization occurred throughout the study and setup and operative times were acceptable. Three instrument arms and 1 endoscope were utilized throughout the study allowing 3 arm operating and dynamic retraction. Instrument size was found to limit surgical access and precision particular at the orbital apex.</p><p><strong>Conclusions: </strong>This preclinical study demonstrates that the da Vinci SP can be utilized within the orbit and is feasible for several applications. Robotic surgical systems offer significant advantages over conventional techniques and should be embraced. However, current commercially available robotic platforms are not optimized for the orbit and have their limitations although they may be suitable for some clinical applications.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhage Following Muller's Muscle Conjunctival Resection: Description and Case-Control Study. 穆勒肌结膜切除术后出血:描述与病例对照研究。
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-01-25 DOI: 10.1097/IOP.0000000000002605
David Gu, Liza M Cohen, JooYeon Jung, Daniel B Rootman

Purpose: The purpose of this study was to report a series of patients with postoperative hemorrhage after Muller's muscle conjunctival resection surgery and compare risk factors and outcomes with a control population.

Methods: In this case-control study, records of patients who underwent Muller's muscle conjunctival resection over 5 years were reviewed for a history of postoperative hemorrhage occurring >24 hours after surgery. A 4:1 control population was matched for age and sex. Clinical data collected included demographics, medical history, medications, and subsequent surgery. Preoperative and 3-month postoperative marginal reflex distance 1 were measured digitally using ImageJ. The hemorrhage and control groups were compared using Fisher's exact tests for categorical variables and independent samples t tests for continuous variables.

Results: The hemorrhage group contained 10 patients (mean age 66.4 ± 18.5 years). The control group consisted of 40 age and sex-matched controls. Of 350 charts reviewed, there were 10 cases of postoperative hemorrhage (incidence 2.9%). Hemorrhage occurred a mean of 4.2 ± 1.3 (range 2-7) days after surgery and lasted for a mean of 29.3 ± 19.1 (range 12-72) hours. In all 10 cases, the bleeding resolved with conservative measures. There was no difference between the hemorrhage and control groups in terms of medical conditions, blood thinners, and surgical revision. Preoperative, postoperative, and change in marginal reflex distance 1 did not differ between the hemorrhage and control groups.

Conclusions: Hemorrhage occurs approximately 4-5 days postoperatively in a small percentage of patients undergoing Muller's muscle conjunctival resection surgery. This investigation did not identify any consistent risk factors, and outcomes in this patient population appear no different than controls.

目的:本研究旨在报告一系列穆勒氏肌结膜切除术后出血的患者,并将风险因素和结果与对照人群进行比较:在这项病例对照研究中,研究人员回顾了5年来接受穆勒肌结膜切除术的患者的记录,以了解术后24小时以上的出血史。对照组的年龄和性别为 4:1。收集的临床数据包括人口统计学、病史、用药和后续手术。使用 ImageJ 对术前和术后 3 个月的边缘反射距离 1 进行数字化测量。对出血组和对照组的分类变量进行费雪精确检验,对连续变量进行独立样本 t 检验:结果:出血组有 10 名患者(平均年龄为 66.4 ± 18.5 岁)。对照组包括 40 名年龄和性别匹配的对照者。在查阅的 350 份病历中,有 10 例术后出血(发生率为 2.9%)。出血平均发生在术后 4.2 ± 1.3(范围 2-7)天,平均持续时间为 29.3 ± 19.1(范围 12-72)小时。在所有 10 个病例中,出血都在采取保守措施后得到了缓解。出血组和对照组在医疗条件、血液稀释剂和手术翻修方面没有差异。出血组和对照组在术前、术后和边缘反射距离1的变化方面没有差异:一小部分接受穆勒肌结膜切除手术的患者会在术后约 4-5 天发生出血。这项调查没有发现任何一致的风险因素,该患者群体的结果似乎与对照组无异。
{"title":"Hemorrhage Following Muller's Muscle Conjunctival Resection: Description and Case-Control Study.","authors":"David Gu, Liza M Cohen, JooYeon Jung, Daniel B Rootman","doi":"10.1097/IOP.0000000000002605","DOIUrl":"10.1097/IOP.0000000000002605","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to report a series of patients with postoperative hemorrhage after Muller's muscle conjunctival resection surgery and compare risk factors and outcomes with a control population.</p><p><strong>Methods: </strong>In this case-control study, records of patients who underwent Muller's muscle conjunctival resection over 5 years were reviewed for a history of postoperative hemorrhage occurring >24 hours after surgery. A 4:1 control population was matched for age and sex. Clinical data collected included demographics, medical history, medications, and subsequent surgery. Preoperative and 3-month postoperative marginal reflex distance 1 were measured digitally using ImageJ. The hemorrhage and control groups were compared using Fisher's exact tests for categorical variables and independent samples t tests for continuous variables.</p><p><strong>Results: </strong>The hemorrhage group contained 10 patients (mean age 66.4 ± 18.5 years). The control group consisted of 40 age and sex-matched controls. Of 350 charts reviewed, there were 10 cases of postoperative hemorrhage (incidence 2.9%). Hemorrhage occurred a mean of 4.2 ± 1.3 (range 2-7) days after surgery and lasted for a mean of 29.3 ± 19.1 (range 12-72) hours. In all 10 cases, the bleeding resolved with conservative measures. There was no difference between the hemorrhage and control groups in terms of medical conditions, blood thinners, and surgical revision. Preoperative, postoperative, and change in marginal reflex distance 1 did not differ between the hemorrhage and control groups.</p><p><strong>Conclusions: </strong>Hemorrhage occurs approximately 4-5 days postoperatively in a small percentage of patients undergoing Muller's muscle conjunctival resection surgery. This investigation did not identify any consistent risk factors, and outcomes in this patient population appear no different than controls.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, Clinical and Imaging Characteristics of Superior Ophthalmic Vein Periphlebitis in Thyroid Eye Disease. 甲状腺眼病眼上静脉周围静脉炎的发病率、临床和成像特征
IF 1.2 4区 医学 Q3 OPHTHALMOLOGY Pub Date : 2024-07-01 Epub Date: 2024-01-25 DOI: 10.1097/IOP.0000000000002592
Kendall Goodyear, Sean Ghiam, Jason Strawbridge, Angela J Oh, Pallavi Singh, Kelsey A Roelofs, Daniel B Rootman

Purpose: To determine the prevalence, clinical features, and radiographic findings of superior ophthalmic vein periphlebitis (SOVP) in thyroid eye disease (TED).

Methods: Patients with a clinical diagnosis of thyroid eye disease and contrast-enhanced imaging were included. Imaging was reviewed for the presence of SOVP, and patients with SOVP were compared to those without. A random eye was determined to be the affected eye in patients without SOVP.

Results: A total of 212 patients met the inclusion criteria. Unilateral SOVP was identified in 4.7% of cases. There was no significant difference in age ( p = 0.22), gender ( p = 0.09), or disease duration ( p = 0.14) between patients with and without SOVP. There was a significant ( p < 0.05) difference in stage classification and clinical activity core between the groups. The affected eye in patients with SOVP had significantly ( p < 0.05) greater margin reflex distance 1, degree of relative proptosis, horizontal motility restriction, and vertical motility restriction than in patients without SOVP. There was no significant difference in horizontal strabismus ( p = 1.0), vertical strabismus ( p = 0.87), or relative intraocular pressure ( p = 0.77). On imaging, the maximal diameter of the SR and IR were found to be significantly ( p < 0.05) larger in the affected eye of patients with periphlebitis; however, there was no difference in measured diameter of the medial rectus and ( p = 0.30) or lateral rectus ( p = 0.78).

Conclusions: SOVP is an under-reported imaging finding of thyroid eye disease. It is associated with significantly greater margin reflex distance 1, relative proptosis, and motility restriction on exam as well as larger superior rectus and inferior rectus diameter on imaging. These patients tend to present in the active stage of disease with greater clinical activity score.

简介:目的目的:确定甲状腺眼病(TED)中眼上静脉周围静脉炎(SOVP)的发病率、临床特征和影像学发现:方法:纳入临床诊断为甲状腺眼病并接受对比增强成像检查的患者。方法:纳入临床诊断为甲状腺眼病并接受对比增强成像检查的患者,检查是否存在 SOVP,并将存在 SOVP 的患者与不存在 SOVP 的患者进行比较。在没有 SOVP 的患者中,随机确定一只眼为患眼:共有 212 名患者符合纳入标准。4.7%的病例被确定为单侧SOVP。有 SOVP 和没有 SOVP 的患者在年龄(p = 0.22)、性别(p = 0.09)或病程(p = 0.14)方面没有明显差异。两组患者在分期和临床活动核心方面有明显差异(p < 0.05)。与无 SOVP 患者相比,SOVP 患者患眼的边缘反射距离 1、相对突眼程度、水平运动受限和垂直运动受限均明显增加(p < 0.05)。水平斜视(p = 1.0)、垂直斜视(p = 0.87)和相对眼压(p = 0.77)无明显差异。影像学检查发现,虹膜周围炎患者患眼的SR和IR最大直径显著增大(p < 0.05);但内侧直肌和(p = 0.30)或外侧直肌的测量直径没有差异(p = 0.78):结论:SOVP是甲状腺眼病影像学检查中报告不足的一项发现。结论:SOVP 是一种未被充分报告的甲状腺眼病影像学发现,它与边缘反射距离 1 明显增大、相对突眼、检查时活动受限以及影像学上直肌和下直肌直径增大有关。这些患者往往处于疾病的活动期,临床活动评分较高。
{"title":"Prevalence, Clinical and Imaging Characteristics of Superior Ophthalmic Vein Periphlebitis in Thyroid Eye Disease.","authors":"Kendall Goodyear, Sean Ghiam, Jason Strawbridge, Angela J Oh, Pallavi Singh, Kelsey A Roelofs, Daniel B Rootman","doi":"10.1097/IOP.0000000000002592","DOIUrl":"10.1097/IOP.0000000000002592","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the prevalence, clinical features, and radiographic findings of superior ophthalmic vein periphlebitis (SOVP) in thyroid eye disease (TED).</p><p><strong>Methods: </strong>Patients with a clinical diagnosis of thyroid eye disease and contrast-enhanced imaging were included. Imaging was reviewed for the presence of SOVP, and patients with SOVP were compared to those without. A random eye was determined to be the affected eye in patients without SOVP.</p><p><strong>Results: </strong>A total of 212 patients met the inclusion criteria. Unilateral SOVP was identified in 4.7% of cases. There was no significant difference in age ( p = 0.22), gender ( p = 0.09), or disease duration ( p = 0.14) between patients with and without SOVP. There was a significant ( p < 0.05) difference in stage classification and clinical activity core between the groups. The affected eye in patients with SOVP had significantly ( p < 0.05) greater margin reflex distance 1, degree of relative proptosis, horizontal motility restriction, and vertical motility restriction than in patients without SOVP. There was no significant difference in horizontal strabismus ( p = 1.0), vertical strabismus ( p = 0.87), or relative intraocular pressure ( p = 0.77). On imaging, the maximal diameter of the SR and IR were found to be significantly ( p < 0.05) larger in the affected eye of patients with periphlebitis; however, there was no difference in measured diameter of the medial rectus and ( p = 0.30) or lateral rectus ( p = 0.78).</p><p><strong>Conclusions: </strong>SOVP is an under-reported imaging finding of thyroid eye disease. It is associated with significantly greater margin reflex distance 1, relative proptosis, and motility restriction on exam as well as larger superior rectus and inferior rectus diameter on imaging. These patients tend to present in the active stage of disease with greater clinical activity score.</p>","PeriodicalId":19588,"journal":{"name":"Ophthalmic Plastic and Reconstructive Surgery","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139576120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmic Plastic and Reconstructive Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1